Financials

  • Market Capitalization 3.82 B
  • Employee 1 184
  • Founded 2015
  • CEO Christian Behrenbruch
  • Website www.telixpharma.com
  • Headquarter Australia
  • FIGI BBG01N69K900
  • Industry Biotecnologia
Receita total
Lucro líquido
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
1534
AMLX
Amylyx Pharmaceuticals, Inc. - Common Stock
34.74 USD-6.56%-10.09%+76.43%+277.61%3.87 B USD
1542
DNLI
Denali Therapeutics Inc. - Common Stock
24.00 USD-2.72%-3.54%0.00%+48.42%3.84 B USD
1558
VKTX
Viking Therapeutics, Inc. - Common Stock
32.16 USD-5.02%-4.63%-4.06%+19.24%3.75 B USD
1563
RCUS
Arcus Biosciences, Inc. Common Stock
29.19 USD-4.61%-4.30%+6.46%+176.42%3.72 B USD